A study to assess the clinical impact, utilization, and safety of Aloe Vera, WHEat Germ Oil, Tea Tree Extract, Honey based emollient cream in patients with dry skin conditions.

A PATIENT REPORTED OUTCOME STUDY TO ASSESS THE CLINICAL IMPACT, UTILIZATION AND SAFETY OF ALOE VERA + WHEAT GERM OIL + TEA TREE EXTRACT + HONEY BASED EMOLLIENT CREAM IN MANAGEMENT OF DRY SKIN CONDITIONS (WHEARA STUDY)

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2023/06/053853

Enrollment

2250

Registered

2023-06-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Emollient Cream: Ingredients - Aloe VeRA 10.00%w/w, WHEat Germ Oil 0.60%w/w, - Tea Tree Extract 0.10%w/w, Honey 1.00%w/w Mode of Application- Apply three or four times daily on the aff

Eligibility

Inclusion criteria

Inclusion criteria: 1)patients with dry skin conditions 2)Clinical cases requiring or maintenance therapy with emollients monocomponent 3)Adults- 18 to 65 years age

Exclusion criteria

Exclusion criteria: Allergic skin diseases other than cases of Dry Skin

Design outcomes

Primary

Measure	Time frame
Safety Assessment Timepoint: at 8 weeks	—

Secondary

Measure	Time frame
Patient assessed outcome for quality of LifeTimepoint: At 8 weeks;Patient assessed outcomes for Atopic DermatitisTimepoint: Throughout the study;Patient assessed outcomes for Dry SkinTimepoint: At 8 weeks;PGA ScoresTimepoint: At 4-8 weeks	—

Countries

India

Contacts

Public ContactDr Rathish Nair PhD MBA

Torrent Pharmaceuticals Ltd

krishnaprasadkorukonda@torrentpharma.com7069000572

Outcome results